Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Gait Dysfunction in Parkinson's Disease
NCT04403399Phase 2Completed
- Sponsor
- University of Michigan
- Start
- Jun 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varenicline in Parkinson's disease (PD), sponsored by University of Michigan. Started Jun 2017; status: completed.
02
Drugs
varenicline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04403399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04403399.